Open toolbar Making life’s moments magical, again. At Alimera Sciences, we’re dedicated to making innovative, vision-improving treatments available for diseases of the retina so you can look forward to all life has to offer. Retinal disease is our focus. Why? Because we’re passionate about the retina as it enables us to see our world, converting light to images in our brain. And we believe that diseases of the retina are not well treated with current therapies and will affect millions of people in aging populations. LEARN MORE We’re dedicated to commercializing and developing innovative, vision-improving treatments for retinal diseases and are always looking forward to helping patients see better longer, every day. Alimera Sciences is a publicly traded pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases. Facebook LinkedIn Alimera Sciences Corporate Offices 6120 Windward Parkway Suite 290 Alpharetta, GA 30005 Phone: +1 (678) 990-5740 toll-free +1 (844) 445-8843 Twitter: @alimerasciences European Website Copyright 2021 Alimera Sciences. This site intended for U.S. residents only. | Legal Statement | Privacy Policy | Privacy Shield Policy | Contact Us You appear to be outside the United States. Would you like to be redirected to our international site? By going to the US site, you are agreeing to our terms and conditions. Go to AlimeraSciences.eu Stay on US website × ×

Open toolbar Our vision. Our mission. Our Vision is for Alimera to be synonymous with good retinal health. We are a company of people with a passion for protecting the retina to preserve vision. People who want to work hard, collaborate and commercialize products that will help patients maintain their vision longer. Our Mission is to be invaluable to patients, physicians and partners concerned with retinal health. ‘Find a way.’ At Alimera we believe in finding a way to succeed in everything we do. And we are driven to find ways to help patients maintain vision longer. At Alimera Sciences, we’re inspired to find a way by being patient-centric, collaborative, motivated, resourceful and accountable. Rick Eiswirth President & Chief Executive Officer Philip Ashman Chief Operating Officer Senior Vice President Commercial Operations Europe Dave Holland Chief Marketing Officer Senior Vice President Corporate Communications & Managed Markets Phil Jones Chief Financial Officer MANAGEMENT TEAM Our board represents diverse and extensive medical and business backgrounds. BOARD OF DIRECTORS Alimera Sciences is a publicly traded pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases. Facebook LinkedIn Alimera Sciences Corporate Offices 6120 Windward Parkway Suite 290 Alpharetta, GA 30005 Phone: +1 (678) 990-5740 toll-free +1 (844) 445-8843 Twitter: @alimerasciences European Website Copyright 2021 Alimera Sciences. This site intended for U.S. residents only. | Legal Statement | Privacy Policy | Privacy Shield Policy | Contact Us ×